Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3442 of 6351
-
New eye scan may spot glaucoma before vision loss begins
Diagnosis CompletedGlaucoma is the first cause of irreversible blindness worldwide with more than 60 millions people affected in 2010. It is defined as a neurodegenerative disease characterized by a progressive loss of retinal ganglion cells (RGC), visual field deterioration and optic nerve excavat…
Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Experimental drug roscovitine tested in cystic fibrosis patients
Disease control Stopped earlyThis is a phase II, dose ranging, multicenter, randomized, double-blind, placebo-controlled study. The aim of this study is to assess the safety of increasing doses of roscovitine administered orally for 4 cycles of 4 consecutive days (treatment "on") separated by a 3 days treat…
Phase 2 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New ultrasound technique may predict chemo response in breast cancer
Diagnosis CompletedAssess the accuracy of the sequential measurements by 3D Shear Wave Elastography (SWE) for predicting histological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
New combo therapy shows early promise for hard-to-treat colorectal cancer
Disease control CompletedThis study is being done to test the safety and effectiveness of the combination of intravenous (IV) romidepsin and/or oral 5-azacitidine with IV MK-3475 in people with microsatellite stable (MSS) advanced colorectal cancer.
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Psoriatic arthritis drug apremilast tracked for two years in Real-World study
Disease control CompletedA total of approximately 500 patients with active psoriatic arthritis in an estimated 80 to 100 trial centers are to be enrolled. Selection of centers will be made by the sponsor's medical section. To increase the quality of the data and to reduce distribution of the data collect…
Sponsor: Amgen • Aim: Disease control
Last updated Jun 26, 2026 12:42 UTC
-
Virtual reality test reveals hidden memory damage in cured Cushing's patients
Knowledge-focused CompletedCushing's disease is a state of chronic endogenous glucocorticoid excess. Cushing's disease is responsible for increased morbidity and mortality. Recent studies have pinpointed the frequency of somatic sequelas and persistent alteration in quality of life despite the cure of the …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Scientists hunt for hidden cancer genes in young patients
Knowledge-focused Stopped earlyDespite relevant clinical and/or familial presentations suggesting a hereditary predisposition (early-onset, multiple primary tumors, familial aggregation), targeted genomic analysis based on the phenotype are often non contributive. As somatic cancer genes are limited, the hypot…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Could a peptide help control obesity and blood pressure?
Disease control Recruiting nowThe overall purpose of this study is to learn more about the metabolic effects of angiotensin-(1-7) in the insulin resistant state associated with obesity. Pharmacologic approaches to increase angiotensin-(1-7) levels or its actions are currently in development for treatment of m…
Phase 1 • Sponsor: Vanderbilt University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
A computer program may help tame depression and stress — without a therapist
Symptom relief Recruiting nowThe investigators have developed interactive, multimedia-intensive, computer-based treatment programs that include depression (Problem-Solving Therapy), stress management, and conflict management. Together the three modules are called PATH. The problem-solving module is based on…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Can kangaroo care and baby massage boost preterm development?
Knowledge-focused CompletedThere are several intervention programs involving multisensory and motor stimulations such as, gym, auditory, visual, vestibular and tactile stimulations. We propose to study a continuous program of early intervention involving very preterm infants' families in their first 12 mon…
Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New drug hopes to boost Radiation's punch against tough gut cancers
Symptom relief OngoingThis phase I trial studies the side effects and best dose of ropidoxuridine in treating patients with gastrointestinal cancer that has spread to other places in the body and usually cannot be cured or controlled with treatment undergoing radiation therapy. Ropidoxuridine may help…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Scientists hunt for drug targets in rare kidney disorder
Knowledge-focused Recruiting nowNephronophthisis (NPH) is an autosomal recessive, genetically heterogeneous disease, with mutations identified in over 20 genes (notably NPHP1 and NPHP4). These genetic defects are associated with reduced urine concentration, chronic tubulointerstitial nephritis, etc., and progr…
Sponsor: Imagine Institute • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:13 UTC
-
Zapping the brain to lift Parkinson's fog and sadness
Symptom relief PausedThis study evaluates the effect of transcranial direct current stimulation (tDCS) on non-motor symptoms of Parkinson's disease, including depression and cognitive symptoms. Participants are randomized to receive active or sham tDCS for 30 minutes over 10 treatment sessions.
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New ointment shows promise for stubborn hand eczema
Symptom relief CompletedTo compare the efficacy of twice daily applications of LEO 124249 ointment with LEO 124249 ointment vehicle for up to 8 weeks in the treatment of subjects with chronic hand eczema.
Phase 2 • Sponsor: LEO Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
French study tracks Real-World use of TNF blockers in early arthritis
Knowledge-focused CompletedAim: To describe 1) The use of TNF blockers in early arthritis in daily clinical practice in France 2) To evaluate symptomatic, structural efficacy, and retention rate over 5 years 3) To evaluate predictive factors for TNF blocker response Type of study: Observational cohort stud…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could wearable sensors spot delirium before doctors do?
Knowledge-focused OngoingDelirium, as a common complication of hospitalization, poses significant health problems in hospitalized patients. Though about a third of delirium cases can benefit from intervention, detecting and predicting delirium is still very limited in practice. A common characterization …
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Could a simple conversation change how doctors treat mental illness?
Knowledge-focused CompletedA growing number of trials have demonstrated treatment effectiveness for people with mental illness (PWMI) by non-specialist providers, such as primary care and community health workers, in low-resource settings. A barrier to scaling up these evidence-based practices is the limit…
Sponsor: Brandon A Kohrt, MD, PhD • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Natural brain hormone could tame autism irritability
Symptom relief CompletedThis is a research study to examine the tolerability and effectiveness of pregnenolone in individuals with autism. Pregnenolone is a naturally occurring steroid hormone in the brain that has been implicated in treating various psychiatric conditions. The investigators hope to lea…
Phase 2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Shrimp-Derived nanoparticles take on denture fungus
Disease control CompletedThe purpose of this study is to evaluate and compare the clinical efficacy of a 1% nanochitosan solution versus a standard Nystatin oral suspension in patients diagnosed with Newton's type II denture stomatitis (chronic atrophic candidiasis). Chitosan nanoparticles are investigat…
Phase 2 • Sponsor: Kerman University of Medical Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Aspirin may help prevent return of precancerous esophagus condition
Disease control OngoingThis randomized phase II trial studies the safety of and how well aspirin works in preventing Barrett's esophagus from returning after it has been successfully eliminated by radiofrequency ablation. Studying samples of tissue from patients with Barrett's esophagus for the levels …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC